Navigation Links
VioQuest Pharmaceuticals Completes Enrollment of Phase I Trial of Lenocta(TM)
Date:10/10/2007

(NDA) to the U. S. Food and Drug Administration (FDA) in 2007 for Lenocta(TM) for the treatment of leishmaniasis.

Forward-Looking Statements

This press release contains forward-looking statements that involve risks and uncertainties that could cause VioQuest's actual results and experiences to differ materially from the anticipated results and expectations expressed in these forward-looking statements. These forward-looking statements concern the timing, progress and results of the clinical development, regulatory processes, and potential clinical trial initiations of Lenocta. These statements are often, but not always, made through the use of words or phrases such as anticipates, expects, plans, believes, intends, and similar words or phrases. These statements are based on current expectations, forecasts and assumptions that are subject to risks and uncertainties, which could cause actual outcomes and results to differ materially from these statements. These statements are subject to various risks and uncertainties and include the possibility that the results of clinical trials will not support VioQuest's claims, the possibility that VioQuest's development efforts relating to its product candidates, including Lenocta(TM), will not be successful, the inability to obtain regulatory approval of VioQuest's product candidates, VioQuest's reliance on third-party researchers to develop its product candidates, its lack of experience in developing and commercializing pharmaceutical products, and the possibility that its licenses to develop and commercialize its product candidates may be terminated. Additional risks are described in VioQuest's Annual Report on Form 10-KSB for the year ended December 31, 2006. VioQuest assumes no obligation and does not intend to update these forward-looking statements, except as required by law.

Contact information:

Daniel Greenleaf

President and CEO

908-766-4400 ext. 115


SOURCE VioQuest Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. VioQuest Pharmaceuticals Announces Data Presentation for Its Akt Inhibitor VQD-002, at American Association for Cancer Research Annual Meeting
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... -- Reportlinker.com announces that a new market research report is ... Taiwanese Markets for Minimally Invasive Spinal Devices ... market for MIS spinal devices in the ... a fast pace, albeit at different rates in different ... China , where MIS spinal fusion is ...
(Date:9/2/2014)... commands the vital signs monitoring devices market with over ... . The North American and European vital signs monitors ... million, respectively, by the end of 2013. They have ... number of elderly people across these economies. The European ... owing to the rising demand for home health patient ...
(Date:9/2/2014)... 2014 According to a ... "Latin America Home Healthcare Market (By Device Types: ... Mobility Assist Devices and Medical Supplies; By Services: ... and Unskilled Home Healthcare Services) - Industry Analysis, ... 2020" the Latin American Home Healthcare market was ...
Breaking Medicine Technology:Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 2Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 3Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 4Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 5Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 6Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 7Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 8Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 9Market of Vital Signs Monitoring Devices Forecast to 2018 2Market of Vital Signs Monitoring Devices Forecast to 2018 3Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 2Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 3Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 4Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 5Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 6
... announced today that Apligraf®, the only product with FDA ... and venous leg ulcers, will have two new procedure ... Services (CMS) as of January 2011. The new codes ... application of Apligraf in accordance with its FDA labeling ...
... 10, 2010 Filtrona Porous Technologies, a custom ... fiber components designed to absorb, retain, transfer, filter ... expanded range of polyurethane foams and bonded fibers ... Dusseldorf, Germany from 17 to 19 November 2010. ...
Cached Medicine Technology:Apligraf Reimbursement to Benefit from New CMS Codes 2
(Date:9/2/2014)... the levels of sex hormones in patients, blood may identify ... rhythm disorder that is fatal in 95 percent of patients. ... journal Heart Rhythm , shows that lower levels of ... who had a sudden cardiac arrest. Higher levels of estradiol, ... chances of having a sudden cardiac arrest in both men ...
(Date:9/2/2014)... VAThe latest research on sleep apnea, tonsillectomies, hearing ... topics will be presented in Orlando, FL, September ... EXPO℠ of the American Academy of OtolaryngologyHead and ... of ear, nose, throat, head and neck physicians ... to be presented were released today, and are ...
(Date:9/2/2014)... Evolve Medical Clinics, the first truly ... care arena, is having its Grand Opening Saturday ... fair the clinic is sponsoring. Evolve offers affordable ... in achieving high quality, convenient medical care. ... a groundbreaking change in healthcare. The membership and ...
(Date:9/2/2014)... CITY, GA (PRWEB) September 02, 2014 Last ... whole new level with the launch of a luxurious line ... to announce that the SEA ISLAND COTTON Socks are joining ... compression level, giving more people the comfort of natural cotton ... COTTON Socks, they are surprised to find socks as soft ...
(Date:9/2/2014)... New York, NY (PRWEB) September 02, 2014 ... international soccer tickets. The first week in September will ... States. Teams from Brazil, Colombia, Mexico, Chile, Ecuador and ... The following matches will take place between September 5th ... MetLife Stadium on Tuesday, September 9th , Mexico ...
Breaking Medicine News(10 mins):Health News:Study links sex hormone levels in the blood to risk of sudden cardiac arrest 2Health News:Evolve Medical Clinics Announces Grand Opening of Annapolis, Maryland Location 2Health News:Evolve Medical Clinics Announces Grand Opening of Annapolis, Maryland Location 3Health News:SIGVARIS’ Luxury Line of Compression Socks, SEA ISLAND COTTON, Now Available in Stronger Compression Level 2Health News:Ticket Down Substantially Slashes Ticket Prices on Brazil vs. Ecuador Tickets, Brazil vs. Colombia Tickets, Mexico vs. Chile Tickets and Mexico vs. Bolivia Tickets 2Health News:Ticket Down Substantially Slashes Ticket Prices on Brazil vs. Ecuador Tickets, Brazil vs. Colombia Tickets, Mexico vs. Chile Tickets and Mexico vs. Bolivia Tickets 3
... risk for asthma, other respiratory problems, CDC report says , , ... kids with food allergies has soared 18 percent in the ... teens now affected with the condition, a new federal report ... age of 18 were reported to have had a food ...
... Calif., Oct. 22 Endocare, Inc.,(Nasdaq: ENDO ), ... minimally invasive technologies for tissue and tumor,ablation, today announced ... the Oppenheimer 19th Annual Healthcare Conference at 1:20,p.m. ET ... held at the,Waldorf Astoria hotel November 3-4 in New ...
... adds affordable, professionally refurbished ultrasound machines to its extensive product ... ... October 22, 2008 -- DRE Inc. - named by Business ... Louisville, Ky. — now sells professionally refurbished ultrasound machines ...
... Engineering, a cleanroom manufacturer, introduces new product that allows more efficient ... ... October 22, 2008 -- Gerbig Engineering, a designer, fabricator and installer ... a new structural aluminum extrusion that integrates into the AireCell line ...
... Pet owners can learn the signs of poor heart health, how to diagnose ... ... October 21, 2008 -- Heart disease is a principle cause of death in ... percent of aged dogs. A new Web site devoted to this issue - ...
... new study by researchers at the University of ... eliminates the need for steroid therapy as early ... still maintaining kidney function. , Steve Woodle, ... investigator and designer of the study, says the ...
Cached Medicine News:Health News:Food Allergies Up 18% Among U.S. Children 2Health News:Endocare to Present at Oppenheimer 19th Annual Healthcare Conference 2Health News:DRE Medical Equipment Adds Affordable Refurbished Ultrasound Machines to Product Line 2Health News:DRE Medical Equipment Adds Affordable Refurbished Ultrasound Machines to Product Line 3Health News:Gerbig Engineering Introduces 7 " Deep Extrusions for Cleanroom Construction 2Health News:New Web Site Devoted to Canine Heart Disease - A Leading Cause of Death in Dogs 2Health News:Study shows steroid therapies following transplant can be eliminated 2
Round, height-adjustable, steel laboratory stools with small footprint for small spaces • Choose options like different height-adjustment mechanism or paint finish. • your choice of color...
... cleanroom for biological safety labs (BSL) ... (to Class 10/ISO 3) and easy ... ultra-smooth surfaces that are easy to ... corners simplify cleaning. Unique double-wall panel ...
Inquire...
Inquire...
Medicine Products: